Can I get it?
Yes, if a doctor decides it is right for you. Semaglutide is authorised in the EU and can be prescribed after a medical review.
Semaglutide · ZaragozaPrescription only
Online medical consultation for Semaglutide in Zaragoza.
An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription valid in any pharmacy in Spain. Consultation €25/month, refunded if the doctor decides it is not safe to prescribe.
- Taken just once a week
- Curbs appetite and cravings
- Studied in large clinical trials for weight loss
Start consultationStart consultation · €25/month
Full refund if a review is not approved · Medication, if prescribed, is dispensed and paid for separately at a pharmacy.
IN PLAIN TERMS
What Semaglutide is, and how to get treatment
Semaglutide is a medicine given as an injection under the skin once a week. It copies a natural gut hormone called GLP-1 that your body makes after eating, so you feel full sooner and stay full longer, and most people end up eating less. In the EU the product authorised for weight management is Wegovy, used together with a reduced-calorie diet and more physical activity. The same active ingredient is also sold as Ozempic, but that is a separate product authorised for type 2 diabetes, not for weight management.
Semaglutide has been authorised for use in the EU since 6 January 2022, so a licensed doctor can prescribe it when it is clinically appropriate for you.
Learn more about peptides at Peptidepedia.
What can I take instead?
Our doctors review every Weight loss option and recommend what fits your history and goals.
See all Weight loss optionsWhat do the studies show?
Every trial behind Semaglutide is listed below with its registry number, how many people took part, and whether the results are peer-reviewed or a company announcement.
Jump to the studiesLocal consultation facts
Can I get Semaglutide in Zaragoza?
Yes. People in Zaragoza, Spain, can request an online doctor consultation about Semaglutide with Hi-Doctor. A licensed EU doctor reviews the case and issues a prescription only when clinically appropriate. If approved, the electronic prescription arrives as a QR code that can be dispensed directly in Spain.
Availability
Semaglutide is available to residents of Spain through the online consultation. A prescription follows only if the doctor approves it.
- Country
- Spain
- Language of service
- Spanish and English
- Prescription turnaround
- In less than 4 hours on average, only if the doctor approves
- Honoured locally
- QR electronic prescription, dispensed directly in Spain
How the EU prescription works where you are: In Spain, an approved prescription arrives electronically with a QR code for direct dispensing.
VERIFIED EVIDENCE
Semaglutide: evidence and regulatory guide.
WHAT IT IS
How it works
It copies GLP-1, a hormone the gut releases after a meal, which reduces appetite and slows how quickly the stomach empties.
- GLP-1
DEVELOPMENT STAGE
EU-authorised medicine
Trial register1 registered trials
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| STEP 1NCT03548935 | Adults with a BMI of 30 kg/m² or more, or 27 kg/m² or more with at least one weight-related condition, without type 2 diabetes; all received lifestyle counselling | 1,961 | Read out | 2021-03-18 |
What the studies reported
Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.
Peer-reviewed
Wilding JPH, Batterham RL, Calanna S, et al; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183 (PMID 33567185)| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| 2.4 mg once weekly | −14.9% | 68 |
| Placebo | −2.4% | 68 |
Everyone in the trial also followed a reduced-calorie diet and increased physical activity, people with type 2 diabetes were excluded, and the study measured weight only up to week 68.
NAMED SAFETY SIGNALS
What has been reported with Semaglutide.
Nausea
Reported by 38.3% of people on semaglutide 2.4 mg versus 14.0% on placebo across the pooled STEP 1–4 phase 3 programme assessed by the EMA.
Diarrhoea
Reported by 26.8% on semaglutide 2.4 mg versus 14.3% on placebo in the same pooled programme.
Vomiting
Reported by 21.8% on semaglutide 2.4 mg versus 5.7% on placebo in the same pooled programme.
Constipation
Reported by 21.8% on semaglutide 2.4 mg versus 10.2% on placebo in the same pooled programme.
Gallbladder problems
Gallbladder-related events were reported by 2.5% on semaglutide 2.4 mg versus 1.6% on placebo, mainly gallstones (1.6% versus 1.1%).
Acute pancreatitis
Independently confirmed in 4 people (0.2%) on semaglutide 2.4 mg and 1 person (under 0.1%) on placebo in the pooled programme.
Stopping treatment because of side effects
5.7% of people on semaglutide 2.4 mg stopped treatment because of side effects versus 3.0% on placebo, mostly because of stomach and bowel symptoms.
FormPre-filled injection pen
FrequencyOnce a week
ResultsGradual, over ~16 weeks
StatusPrescription only
About
What is Semaglutide?
Active ingredient: Semaglutide · Dosages: 0.25 – 2.4 mg / week
Semaglutide is a GLP-1 receptor agonist — a medication that mimics a natural hormone your gut releases after eating. It reduces appetite, slows gastric emptying and helps maintain sustained weight loss when combined with supervised nutrition and activity changes.
It's prescribed alongside changes to diet and activity, as part of a medically supervised plan — not on its own, and not as a shortcut. A licensed EU doctor decides whether it's appropriate and safe for you.
How it works in the body
Semaglutide may reduce appetite and slow how quickly your stomach empties, so you tend to feel full sooner and eat less. Effects build gradually and vary from person to person.
How it helps
Three ways it supports weight loss.
Eases appetite
Acts on hunger signals, so many people feel satisfied with less food.
Slows digestion
Food stays in your stomach longer, so you tend to feel full for longer.
Part of a plan
Prescribed alongside support for diet and activity — never as a standalone fix.
What to expect
A gradual, supervised start.
The dose is increased slowly over 16 weeks to help your body adjust and to ease side effects. Your doctor sets your exact schedule.
- Weeks 1–4 · Lowest dose
- Weeks 5–16 · Step up gradually
- Month 4+ · Maintenance dose
- Ongoing · Regular check-ins
Typical escalation
- Weeks 1–40.25 mg / week
- Weeks 5–80.5 mg / week
- Weeks 9–121 mg / week
- Weeks 13–161.7 mg / week
- Maintenanceup to 2.4 mg / week
Your schedule is personal
These are typical steps only. Your doctor adjusts the plan to how you respond and tolerate it — and you can message them at any point.
Safety first
Safety, in full.
Semaglutide is an effective medicine — and like any medicine it carries risks. Your doctor screens for all of this before prescribing. Here's the honest picture, not just reassurance.
Adults with obesity (BMI ≥30) or with overweight (BMI ≥27) plus at least one weight-related condition such as type 2 diabetes, hypertension or dyslipidaemia.
- Once-weekly self-injection in the thigh, abdomen or upper arm.
- Dose is escalated gradually (0.25 mg → 0.5 → 1.0 → 1.7 → 2.4 mg) over 16 weeks to limit gastrointestinal side effects.
- Combined with diet and physical activity — semaglutide is not a substitute for lifestyle change.
Who should not take it
- Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2).
- Pregnancy, planned pregnancy in the next 2 months, or breastfeeding.
- History of pancreatitis or active pancreatic disease.
- Type 1 diabetes or diabetic ketoacidosis — semaglutide is not approved here.
- Severe gastroparesis or chronic severe gastrointestinal disease.
When to seek urgent care
For severe, sudden or unexpected symptoms, call your local emergency number or go to the nearest emergency department. Then let your doctor know through your account chat.
PRICING
You only pay if treatment is approved.
€25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth. €35 one-off is available for sexual health.
Weight loss
ONGOING PLAN
€25/month
Billed €25 every 28 days · cancel anytime
28-day treatment cycle
For ongoing treatment and doctor-reviewed renewals.
Renewals reviewed by your doctor
Start consultation
Full refund if a review is not approved
WHAT'S INCLUDED
- First consultation included
- Renewals reviewed by your doctor
- Ongoing care with your doctor
- Cancel anytime
Full refund if a review is not approved
If a review is not approved, we refund that period's €25 fee and cancel the plan.
Note: The medication, if the doctor prescribes it, is paid separately at the pharmacy at the price it sets. Hi-Doctor does not sell medications.
HOW THE DOCTOR DECIDES
A licensed doctor reviews your case, not an algorithm
An EU-licensed doctor reads your questionnaire and answers in less than 2 hours on average.
If the doctor decides it is not safe to prescribe, the consultation fee is refunded in full.
Follow-up happens in the private chat inside your account, under GDPR. No WhatsApp, no SMS.
OTHER WEIGHT LOSS TREATMENTS
Explore related treatments.
Find out if it's right for you
See if Semaglutide is appropriate for you.
Answer a few questions and a licensed EU doctor reviews your case in less than 2 hours on average. Refunded in full if it's not right for you.